| Product Code: ETC10070176 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Cell And Gene Therapy CDMO Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Cell And Gene Therapy CDMO Market - Industry Life Cycle |
3.4 Vietnam Cell And Gene Therapy CDMO Market - Porter's Five Forces |
3.5 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.6 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Vietnam Cell And Gene Therapy CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in the field of cell and gene therapy within Vietnam |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Favorable regulatory environment supporting the development and commercialization of cell and gene therapy products |
4.3 Market Restraints |
4.3.1 Limited infrastructure and expertise in cell and gene therapy manufacturing in Vietnam |
4.3.2 High costs associated with cell and gene therapy manufacturing processes |
4.3.3 Challenges in intellectual property protection and technology transfer in the Vietnamese market |
5 Vietnam Cell And Gene Therapy CDMO Market Trends |
6 Vietnam Cell And Gene Therapy CDMO Market, By Types |
6.1 Vietnam Cell And Gene Therapy CDMO Market, By Phase |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F |
6.1.3 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F |
6.1.4 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.2 Vietnam Cell And Gene Therapy CDMO Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2.3 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F |
6.2.4 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3 Vietnam Cell And Gene Therapy CDMO Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.4 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F |
6.3.5 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.3.6 Vietnam Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Cell And Gene Therapy CDMO Market Import-Export Trade Statistics |
7.1 Vietnam Cell And Gene Therapy CDMO Market Export to Major Countries |
7.2 Vietnam Cell And Gene Therapy CDMO Market Imports from Major Countries |
8 Vietnam Cell And Gene Therapy CDMO Market Key Performance Indicators |
8.1 Number of partnerships and collaborations between local research institutions and international companies in the cell and gene therapy sector |
8.2 Investments in infrastructure development for cell and gene therapy manufacturing facilities in Vietnam |
8.3 Number of clinical trials and regulatory approvals for cell and gene therapy products in Vietnam |
9 Vietnam Cell And Gene Therapy CDMO Market - Opportunity Assessment |
9.1 Vietnam Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.2 Vietnam Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Vietnam Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Vietnam Cell And Gene Therapy CDMO Market - Competitive Landscape |
10.1 Vietnam Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here